Helicobacter pylori infection. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention 1: Intervention group: For patients in the intervention group, after explaining the treatment to the patients and providing the necessary education, standard treatment + probiotics includ
Sponsors
Vice President for Research, Shahrood University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1- Patients with a definitive diagnosis of Helicobacter pylori infection? 2- Age range 15-75 years? 3- Stable vital signs? 4- Informed consent to participate in the research.
Exclusion criteria
Exclusion criteria: 1- Pregnancy or breastfeeding? 2- Prior treatment for Helicobacter pylori infection? 3- Treatment with antibiotics or probiotics at least 1 month before entering the study? 4- Treatment with proton pump inhibitors (PPIs), H2 receptor antagonists, or antacids for at least 2 weeks prior to study entry? 5- Known allergy to any of the antibiotics used in the eradication regimen? 6- Definitive diagnosis of heart disease, heart failure, malignancies, thyroid diseases, pulmonary diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication of Helicobacter pylori. Timepoint: 6 weeks after taking the drug. Method of measurement: Measuring the degree of recovery of Helicobacter pylori infection by standard laboratory methods using fecal antigen testing at baseline and 6 weeks after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measuring the severity of nausea and vomiting using the system (visual analog scale) at the beginning of the study and 6 weeks after treatment. Timepoint: At baseline and 6 weeks after treatment. Method of measurement: With visual analog indicator(VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNaimeh Taherian
Shahroud University of Medical Sciences
Outcome results
None listed